Navigation Links
Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
Date:12/9/2007

LOS ANGELES, Dec. 9 /PRNewswire/ -- A federal court in Los Angeles has opened the door to shining a harsh spotlight on the pharmaceutical firm Johnson & Johnson, whose subsidiary McNeil Nutritionals has been accused of false advertising the controversial chemical sweetener Splenda. United States District Dale S. Fischer rejected Johnson & Johnson's request for summary judgment based on that charge that the plaintiffs had unreasonably delayed bringing suit, and said that the claims against Johnson & Johnson should be heard by a jury at a trial on the merits.

Andy Briscoe, President and CEO of the Washington-based Sugar Association, representing thousands of sugar farmers from across the nation, declared, "This ruling will give consumers a chance to hear the facts in this case. Consumers have a right to know what they really are buying and an equal right not to have a big corporation try to tell them something else. We look forward to the trial."

The central issue before the court is the deceptive nature of the advertising of Splenda -- a chemical sweetener -- to make consumers believe it is a natural product, including the use of the taglines, "Made from sugar, so it tastes like sugar" and "Good for the Whole Family." Internal documents show Johnson & Johnson knew that its Splenda advertising was causing consumers to believe that Splenda, which is made using chlorine, is a natural product, despite it being chemical. Although rulings in France, Australia and New Zealand have found Johnson & Johnson's advertising of Splenda to be deceptive, the company continues to falsely promote Splenda as something that it is not.

Dan Callister, attorney for the Sugar Association, said, "We believe that the facts in this case are clear and compelling. For the second time, a jury will find that Johnson & Johnson has intentionally misled the consumer in its marketing of the chlorinated sweetener Splenda."

It has been estimated that damages in this case could reach $1-billion. The trial currently is scheduled to begin on January 29, 2008, in Los Angeles. Additional background information can be found at http://www.TruthAboutSplenda.com .


'/>"/>
SOURCE Sugar Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations
2. MDMA Names New Director of Federal Affairs
3. Federal research plan to determine nanotech risks fails to deliver
4. Federal Employee Program Maintains Low Health Premiums In 2008
5. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
6. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
7. ACM Helps Medicaid Programs Comply With Federal Deficit Reduction Act Mandates
8. Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid
9. HIV/AIDS Cases Among State and Federal Prison Inmates Fell for the Sixth Straight Year During 2005
10. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
11. Federal Trade Commission Attempts To Suppress Best-Selling Authors First Amendment Rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: